Vistin Pharma
Vær den første som følger denne virksomhed
Vistin Pharma is a Norwegian pharmaceutical company. The company conducts research and development as well as further production of pharmaceutical substances (API), mainly the substances metformin, codeine phosphate, and Pholcodine. The substances are mainly used in the treatment of diabetes. The company operates worldwide, with the largest presence in the Nordic market. Vistin Pharma was founded in 2015 and is headquartered in Oslo, Norway.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
VISTN
Daglig lav / høj pris
-
Markedsværdi
-
Aktieomsætning
-
Volumen
-
Finanskalender
Delårsrapport
23.08.2024
Delårsrapport
31.10.2024
Halvårligt udbytte
06.11.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Intertrade Shipping AS | 28,4 % | 28,4 % |
Holmen Specialfond | 8,7 % | 8,7 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Ex dividend NOK 0.50 today
Vistin Pharma ASA: Minutes from the annual general meeting 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools